Monographs on drugs which are frequently analyzed in therapeutic drug monitoring/Arzneimittel-Monographien für Medikamente, die regelmäßig im Rahmen des Therapeutic Drug Monitorings analysiert werden

J Lab Med 2012;36(2):121 © 2012 by Walter de Gruyter • Berlin • Boston. DOI 10.1515/labmed-2012-0002

Erratum

Drug Monitoring und Toxikologie /

Redaktion: W. Steimer

Drug Monitoring and Toxicology

Monographs on drugs which are frequently analyzed in

therapeutic drug monitoring

Arzneimittel-Monographien f ü r Medikamente, die regelm ä ß ig im

Rahmen des Therapeutic Drug Monitorings analysiert werden

Working Group “ Drug Monitoring ” of the SSCC: Katharina Rentsch (Chair) 1, _{* , Daniela Buhl} 2 _{, Chin}

Bin Eap 3 _{, Marc Fathi} 4 _{, Wolfgang J ö chle} 5 _{, Jean-Luc}

Magnin 6 _{, Wolfgang Thormann} 7 _{and Dominique}

Werner 8

1 _{University Hospital Zurich , Zurich , Switzerland}

2 _{University Hospital Bern , Bern , Switzerland}

3 _{University Hospital Lausanne , Lausanne , Switzerland}

4 _{University Hospital Geneva , Geneva , Switzerland}

5 _{University Hospital Basel , Basel , Switzerland}

6 _{Kantonsspital Freiburg , Freiburg , Switzerland}

7 _{University of Bern , Bern , Switzerland}

8 _{University Hospital Lausanne , Lausanne , Switzerland}

J Lab Med 2010;34:129 – 39:

Topiramat

Conversion factors:

Correct: mg/L × 2.95 = µ mol/L µ mol/L × 0.339 = mg/L

Typical therapeutic ranges:

Correct: 4.0 – 12.2 mg/L (11.8 – 36.0 µ mol/L)

*Correspondence: PD Dr. Katharina Rentsch, University Hospital Z ü rich, Institut f ü r Klinische Chemie, R ä mistra ß e 100, 8091 Z ü rich, Switzerland

Tel.: + 41-44-2552290 Fax: + 41-44-2554590 E-Mail : rentsch@access.uzh.ch